SEARCH
You are in browse mode. You must login to use MEMORY

   Log in to start


From course:

CPO Biologiques

» Start this Course
(Practice similar questions for free)
Question:

Durvalumab (Imfinzy)

Author: Natalia Abesada



Answer:

Anti PD-L1. Ind: monotherapie dans le cancer bronchique non a petites cellules, dont les tumeurs expriment PD-L1.


0 / 5  (0 ratings)

1 answer(s) in total